Verisante Technology Inc (VRSEF) 0.0242 $VRSEF
Verisante Provides Operational Update
ACCESSWIRE - Fri May 20, 3:36PM CDT
VANCOUVER, BC / ACCESSWIRE / May 20, 2016 / Verisante Technology, Inc. (TSXV: VRS) (OTC Pink: VRSEF) (the "Company" or "Verisante"
, a leader in skin cancer detection technology, provides an operational update after releasing its financial statements for the year ended December 31, 2015.
VRS.VN: 0.035 (unch)
Global Dermatology Diagnostics Devices Market 2015-2019
M2 - Thu Sep 24, 10:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fk9wjj/global) has announced the addition of the "Global Dermatology Diagnostics Devices Market 2015-2019" report to their offering. Teledermatology is directed toward improving access to medical consultations while decreasing costs by eliminating travel for patients, physicians, and nurses. The adoption of telemedicine in recent years is rising because of better information technology in terms of affordability and performance. Telemedicine has become a standard in most of the clinical application areas, such as cardiology, orthopedics, and neurology. There is a growing interest in teledermatology because of the increasing need for dermatology services and the lack of specialists or dermatologists in many countries. For example, in the UK there has been an increase by 50% in dermatology referrals in the last decade. However, there are not many dermatologists available in the country to address the concerns. Teledermatology is one solution for the healthcare community to address the dermatology workforce challenge. According to the report, efforts to educate dermatologists and patients are expected to contribute to the growth of global dermatology diagnostic devices market. The initiatives taken by both government and private entities include regular education and training for physicians, conducting public awareness programs, and increase funding for scientific and epidemiological research. There are more than 2,000 recognized skin disorders. The increasing awareness and the need for improvement in diagnostic accuracy have created a relatively new responsibility and interest among practitioners in the field of dermatology. Accurate diagnosis and effective treatment depends on proficiency of general practitioners and dermatologists. Self-diagnosing and self-medicating by patients for dermatological conditions are major factors hindering market growth. Key Topics Covered - Executive summary - Scope of the report - Market research methodology - Introduction - Teledermatology and mobile apps - Market landscape - Market segmentation by application - Market segmentation by product - Geographical segmentation - Market drivers - Impact of drivers - Market challenges - Impact of drivers and challenges - Market trends - Vendor landscape - Major Vendor Analysis 2015 - Key vendor analysis Companies Mentioned - Caliber Imaging & Diagnostic - FotoFinder Systems - Heine Optotechnik - Longport - MedX Health Corp. - Mela Sciences - Michelson Diagnostics - SciBase AB - Verisante Technology - Welch Allyn For more information visit http://www.researchandmarkets.com/research/fk9wjj/global
Verisante Enters Amended Licensing Agreement With the BC Cancer Agency
Marketwired - Thu Jul 09, 8:31AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in skin cancer detection technology, announced today that it has entered into an agreement that amends the licensing agreement (the "Agreement" originally entered into with the BC Cancer Agency ("BCCA" in July 2010.
VRS.VN: 0.035 (unch)
North American Dermatology Treatment Devices Market 2015-2019 - Types (Liposuction, Microdermabrasion, Lasers) & Application (Cancer Diagnosis, Psoriasis, Hair Removal) Analysis
M2 - Tue May 26, 5:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/g3tbwq/north_american) has announced the addition of the "North American Dermatology Treatment Devices Market by Types (Liposuction, Microdermabrasion, Lasers) & by Application (Cancer Diagnosis, Psoriasis, Hair Removal) - Forecast to 2019" report to their offering. The North American dermatology treatment devices market is estimated to grow at a CAGR of 10.1% from 2014 to 2019 The U.S holds the largest share of the dermatology treatment devices market; however, the Canadian market is expected to grow at the highest CAGR of 11.5% during the forecast period. Factors such as rising skin disorders, growing demand for diagnosis from the geriatric population, increasing demand for dermatologists, and technology advantages are driving market growth. However, factors such as lack of awareness, competitive pricing of devices, and lack of dermatology care are hindering the growth of this market. In this report, the North American dermatology treatment devices market has been broadly classified on the basis of types. This includes LED light therapy devices, lasers, electrosurgical equipment, liposuction devices, microdermabrasion, and cryotherapy. The lasers segment held the largest share in the treatment devices market, growing at a CAGR of 12.3% during the forecast period. Geographically, the U.S commanded the largest share of 86.0% of the North American dermatology treatment devices market in 2014, followed by Canada. The dermatology treatment devices market in the U.S. is primarily driven by increasing demand from the geriatric population and rise in insurance coverage among citizens due to increasing employment. Canada is the fastest-growing market in the North American region, growing at a CAGR of 11.5% during the forecast period. The North American dermatology treatment devices market is a competitive market with a number of market players. As of 2014, the North American dermatology treatment devices market is estimated to be dominated by Photomedex, Inc., Verisante technology, Inc., MELA Sciences, Inc., Michelson diagnostics Ltd, Leica Microsystems, Fotofinder systems GMBH, FEI Company, Solta medical, Syneron medical Ltd., Lumenis Ltd., Cutera, Inc., Cynosure, Inc., AMD global telemedicine Inc, Ambicare Health Ltd, and ALMA Lasers, Ltd. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 North American Dermatology Treatment Devices Market, By Product 6 North American Dermatology Treatment Devices Market, By End User 7 North American Dermatology Treatment Devices Market, By Country 8 Dermatology Treatment Devices Market: Competitive Landscape 9 Dermatology Treatment Devices Market, By Company - ALMA Lasers, Ltd. - AMD Global Telemedicine Inc. - Ambicare Health Ltd - Cutera, Inc. - Cynosure, Inc. - FEI Company - Fotofinder Systems GMBH - LEICA Microsystems - Lumenis Ltd. - MELA Sciences, Inc. - Michelson Diagnostics Ltd. - Photomedex, Inc. - SOLTA Medical - Syneron Medical Ltd. - Verisante Technology, Inc. For more information visit http://www.researchandmarkets.com/research/g3...h_american
ELOS: 7.37 (-0.03), CYNO: 54.96 (+1.13), MELA: 1.12 (+0.01), LMNS: 13.76 (+0.04), FEIC: 106.42 (+0.12)
Asian Diagnostic Device Market 2015-2019: Analysis of Diagnostic Device (Dermatoscope, Microscope, Imaging Techniques) & Treatment Devices (Liposuction, Microdermabrasion, Lasers)
M2 - Thu May 07, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t9l5mt/asian_dermatology) has announced the addition of the "Asian Dermatology Diagnostic Devices Market by Diagnostic Device, by Treatment Device, by Application - Forecast to 2019" report to their offering. The Asian dermatology diagnostic devices market is estimated to grow at a CAGR of 6.5% from 2014 to 2019 Although mature markets such as China and Japan hold larger shares in the Asian Ddermatology diagnostic devices market, the Indian region is expected to grow at the highest CAGR of 7.3%. The growth of the Asian dermatology diagnostic devices market is driven by factors such as rising skin disorders, demand for diagnosis by baby boomers, demand for dermatologists, and technology advantages. However, factors such as a lack of awareness and dermatology care are hindering the growth of this market. The market, based on type of product, includes dermatoscopes, imaging techniques, and microscopes. Imaging techniques held the highest share in the market, growing at a CAGR of 7.0% during the forecast period. This is due to their use as in vivo tools; they also help in the detection of later stages of skin disorders. Geographically, China is estimated to have the largest share of 31.0% of the Asian Dermatology diagnostic devices market in 2014, followed by Japan. The dermatology diagnostic devices market in the China region is primarily driven by the increasing prevalence of skin disorders such as melanoma and psoriasis. The fastest-growing Indian market is driven by increasing insurance coverage and the awareness of various skin disorders in this region. The Asian dermatology diagnostic devices market is a competitive market, with a number of players. As of 2014, the Asian Dermatology diagnostic devices market is estimated to be dominated by Heine Optotechnik (Germany), Optomed Oy (Finland), FotoFinder Systems (Germany), Michelson Diagnostics (U.K.), GE Healthcare (U.K.), Philips Healthcare (Netherlands), Welch Allyn (U.S.), Carl Zeiss Meditec, Inc. (U.S.), Hitachi (Japan), Leica Microsystems (Germany), Olympus (Japan), Toshiba Medical Systems (Japan), and Siemens Healthcare (Germany). Companies Mentioned - AMD Global Telemedicine, Inc. - Bruker Corporation - Carl Zeiss - FEI Company - Fotofinder Systems Gmbh - GE Healthcare - Heine Optotechnik - Leica Microsystems - MELA Sciences, Inc. - Michelson Diagnostics Ltd. - Nikon Corporation - Philips Healthcare - Photomedex, Inc. - Siemens Healthcare - Toshiba Medical Systems - Verisante Technology, Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/t9...ermatology
MELA: 1.12 (+0.01), FEIC: 106.42 (+0.12)
Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019
M2 - Fri May 01, 5:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b8f54g/asian_dermatology) has announced the addition of the "Asian Dermatology Devices Market by Type, by End User - Forecast to 2019" report to their offering. The Asian Dermatology Devices market is estimated to grow at a CAGR of 11.3% from 2014 to 2019. China holds a larger share in the Dermatology devices market around 28.8% in 2014 followed by Japan. The Asian Dermatology Devices market holds a high potential for growth in future due to a number of forces favoring this market. These include increasing number of people suffering from skin disorders, demand for devices at a lower cost and increasing awareness aesthetic procedures. However, price sensitive market is having an adverse effect on the dermatology devices market. In this report, the Asian Dermatology devices market is broadly classified on the basis of product types, end users. The products segment is classified into Dermatology treatment devices and Dermatology diagnostic devices. Based on end users, the Dermatology devices market is categorized into Hospitals and Clinics. Geographically the market is divided into eight countries, namely Japan, China, India, Korea, Singapore, Malaysia, Indonesia and Rest of Asia (RoE). China is estimated to command the largest share of 28.7% of the Asian Dermatology Devices market in 2014, followed by Japan. Japan is estimated to grow at a CAGR of 7.9% during the forecast period from 2014 to 2019. Certain factors that influence the demand for the Asian dermatology devices market include the increasing number of people who suffer from skin disorders and the demand for devices at a lower cost. Thus, world-class manufacturers are coming up with devices at a lower price and concentrate on the Asian region to expand their business and geographical reach. Countries in the Asian region, namely India and China have a tropical climate, making the inhabitants of this region extremely prone to sun exposure, particularly skin tanning. Thus, there is an increase in the demand for dermatological treatments that have an impact on the growth of the dermatology diagnostic devices market in Asia. The number of skin cancer cases in Singapore has been increasing. There were 2,819 cases of skin cancer in Singapore from 2008 to 2012, among which 83.0% were Chinese, according to the National Skin Centre, followed by Malays recording 4.5% of the cases. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Asian Dermatology Devices Market, By Type 6 Asian Dermatology Devices Market, By End-User 7 Asian Dermatology Devices Market, By Geography 8 Asian Dermatology Devices Market: Competitive Landscape 9 Asian Dermatology Devices Market: Company Profiles - ALMA Lasers, Ltd. - Ambicare Health Ltd. - amd Global Telemedicine Inc - Applisonix Ltd - Biolitec0020AG - Carl Zeiss - Cynosure, Inc. - Ellipse A/S - fei Company - Fotofinder Systems GMBH - Genesis Biosystems. - Heine Optotechnik - Leica Microsystems - Lumenis Ltd. - Mela Sciences, Inc. - Michelson Diagnostics Ltd - Nikon Corporation - Photomedex, Inc. - Solta Medical, Llc. (Division of Valeant Pharmaceuticals North America, Llc.) - Syneron Medical Ltd - Verisante Technology, Inc. For more information visit http://www.researchandmarkets.com/research/b8...ermatology
ELOS: 7.37 (-0.03), CYNO: 54.96 (+1.13), LMNS: 13.76 (+0.04)
North American Dermatology Devices (Dermatology Treatment Devices, Dermatology Diagnostic Devices) Market 2015 - Forecast to 2019
M2 - Fri Apr 24, 5:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bk922d/north_american) has announced the addition of the "North American Dermatology Devices Market by Type (Dermatology Treatment Devices, Dermatology Diagnostic Devices) - Forecast to 2019" report to their offering. The North American dermatology diagnostic devices market is estimated to grow at a CAGR of 7.9% from 2014 to 2019 Although mature markets (the U.S. and Canada) command larger shares in the dermatology diagnostic devices market, Mexico is expected to grow at the highest CAGR of 9.8% during the forecast period. The growth of the dermatology diagnostic devices market is driven by factors such as rising incidences of skin disorders, increasing demand for diagnosis by baby boomers, need for more dermatologists, and technological advancements. However, factors such as lack of awareness, competitive pricing, and lack of dermatology care are hindering the growth of this market. In this report, the North American dermatology diagnostic devices market has been broadly classified on the basis of types. This segment includes dermatoscopes, imaging techniques, and microscopes. The imaging techniques segment commands the largest share of the dermatology diagnostic devices market, growing at a CAGR of 8.0% during the forecast period (2014 to 2019). This large share is mainly due to the fact that imaging techniques are generally in vivo tools and helps in the detection of later stages of skin disorders. The U.S commanded the largest share of 89.3% of the North American dermatology diagnostic devices market in 2014, followed by Canada. The dermatology diagnostic devices market in the U.S. is primarily driven by the increasing demand from baby boomers and increasing insurance coverage for citizens due to increasing employment. Mexico is the fastest-growing segment in the North American region, at a CAGR of 9.8% during the forecast period. This is due to the increasing insurance coverage and awareness of various skin disorders in this region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 North America Dermatology Devices Market, By Type 6 North America Dermatology Devices Market, By Geography 7 North America Dermatology Devices Market: Competitive Landscape 8 Dermatology Devices Market, By Company - Alma Lasers, Ltd. - Ambicare Health Ltd - Amd Global Telemedicine Inc. - Applisonix Ltd. - Biolitec Ag - Carl Zeiss Meditec - Cutera, Inc. - Cynosure, Inc. - Ellipse A/S - Fei Company - Fotofinder Systems Gmbh - Genesis Biosystems - Leica Microsystems - Lumenis Ltd. - Mela Sciences, Inc. - Michelson Diagnostics Ltd. - Nikon Corporation - Photomedex, Inc. - Solta Medical, - Syneron Medical Ltd. - Verisante Technology, Inc. For more information visit http://www.researchandmarkets.com/research/bk...h_american
ELOS: 7.37 (-0.03), CYNO: 54.96 (+1.13), LMNS: 13.76 (+0.04)
Global Dermatology Diagnostic Devices Market 2015-2019 - Type (Imaging Techniques, Dermatoscopes, Microscopes) & End-User (Hospitals, Clinics) Analysis
M2 - Wed Apr 22, 9:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5qq5d4/dermatology) has announced the addition of the "Dermatology Diagnostic Devices Market by Product [Imaging Techniques (OCT, Ultrasound, MRI, CT), Dermatoscopes (Traditional Dermatoscopes, Digital Dermatoscopes), Microscopes], by End-User (Hospitals, Clinics) - Global Forecast to 2019" report to their offering. The global dermatology diagnostic devices market is estimated to grow at a CAGR of 8.2% from 2014 to 2019 North America and Europe hold larger shares in the global dermatology diagnostic devices market. The growth of the global dermatology diagnostic devices market is mainly attributed to a wide range of factors, such as increasing incidence of skin disorders, growing demand of dermatologists, and technological advancements made in the field of medical science. However, lack of awareness and poor dermatology care are certain factors restraining the growth of this market. In this report, the global dermatology diagnostic devices market has been broadly classified on the basis of types. The type segment includes dermatoscope, imaging technique, and microscope. The imaging technique has the highest market share in the diagnostic device market, registering a CAGR of 8.5% during the forecast period. This growth is mainly triggered by the increasing significance of dermatology techniques and advantages it offers with respect to early detection of skin disorders. Geographically, North America is estimated to have the largest share of 37.1% in the global dermatology diagnostic devices market in 2014, followed by Europe. The dermatology diagnostic devices market in North America is primarily driven by the increasing prevalence of skin disorders, such as melanoma and psoriasis, and highly organized health care infrastructure and guidelines. The European region is the fastest growing region progressing at a CAGR of 9.6% from 2014 to 2019, owing to the increase in insurance coverage, incessant rise in geriatric population, and growing awareness about various skin disorders. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Dermatology Diagnostic Devices Market, By Product 6 Global Dermatology Diagnostic Devices Market, By Geography 7 Global Dermatology Diagnostic Devices Market, By End User 8 Global Dermatology Diagnostic Devices Market: Competitive Landscape 9 Global Dermatology Diagnostic Devices Market, By Company - AMD Global Telemedicine Inc - Bruker Corporation - Carl Zeiss - FEI Company - Fotofinder Systems Gmbh - GE Healthcare - Heine Optotechnik - Leica Microsystems - Mela Sciences, Inc. - Michelson Diagnostics Ltd - Nikon Corporation - Philips Healthcare - Photomedex, Inc. - Seimens Healthcare - Toshiba Medical Systems - Verisante Technology, Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/5q...ermatology
FEIC: 106.42 (+0.12)
Verisante Obtains Mexican Approval
Marketwired - Thu Mar 12, 9:02AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in skin cancer detection technology, announced today that it has received regulatory approval from the Federal Commission for Protection against Sanitary Risks (COFEPRIS), a division within the Mexican Ministry of Health, to market and sell Aura(TM), a device for the detection of skin cancer, in Mexico.
VRS.VN: 0.035 (unch)
Verisante Technology, Inc. Announces Equipment Loan to Further Collaboration With Key Chinese Laboratory
Marketwired - Wed Feb 18, 9:01AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, announced today it has expanded its collaboration with Fujian Normal University in China (the "University" .
VRS.VN: 0.035 (unch)
Verisante Technology, Inc. Announces Brain Tumour Study in the UK
Marketwired - Tue Jan 13, 8:30AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, announced today it has entered into a collaboration with the BC Cancer Agency and Imperial College Healthcare NHS Trust to develop a new application for the Company's exclusively licensed platform technology.
VRS.VN: 0.035 (unch)
Verisante Technology, Inc. Announced Non-Brokered Private Placement and Year End Operational Update
Marketwired - Wed Dec 31, 8:31AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, today announced it has closed a non-brokered private placement of 3,888,889 common shares at a price of $0.09 per share for gross proceeds of $350,000.
VRS.VN: 0.035 (unch)
Verisante Provides Operational Update
ACCESSWIRE - Fri May 20, 3:36PM CDT
VANCOUVER, BC / ACCESSWIRE / May 20, 2016 / Verisante Technology, Inc. (TSXV: VRS) (OTC Pink: VRSEF) (the "Company" or "Verisante"
, a leader in skin cancer detection technology, provides an operational update after releasing its financial statements for the year ended December 31, 2015. VRS.VN: 0.035 (unch)
Global Dermatology Diagnostics Devices Market 2015-2019
M2 - Thu Sep 24, 10:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fk9wjj/global) has announced the addition of the "Global Dermatology Diagnostics Devices Market 2015-2019" report to their offering. Teledermatology is directed toward improving access to medical consultations while decreasing costs by eliminating travel for patients, physicians, and nurses. The adoption of telemedicine in recent years is rising because of better information technology in terms of affordability and performance. Telemedicine has become a standard in most of the clinical application areas, such as cardiology, orthopedics, and neurology. There is a growing interest in teledermatology because of the increasing need for dermatology services and the lack of specialists or dermatologists in many countries. For example, in the UK there has been an increase by 50% in dermatology referrals in the last decade. However, there are not many dermatologists available in the country to address the concerns. Teledermatology is one solution for the healthcare community to address the dermatology workforce challenge. According to the report, efforts to educate dermatologists and patients are expected to contribute to the growth of global dermatology diagnostic devices market. The initiatives taken by both government and private entities include regular education and training for physicians, conducting public awareness programs, and increase funding for scientific and epidemiological research. There are more than 2,000 recognized skin disorders. The increasing awareness and the need for improvement in diagnostic accuracy have created a relatively new responsibility and interest among practitioners in the field of dermatology. Accurate diagnosis and effective treatment depends on proficiency of general practitioners and dermatologists. Self-diagnosing and self-medicating by patients for dermatological conditions are major factors hindering market growth. Key Topics Covered - Executive summary - Scope of the report - Market research methodology - Introduction - Teledermatology and mobile apps - Market landscape - Market segmentation by application - Market segmentation by product - Geographical segmentation - Market drivers - Impact of drivers - Market challenges - Impact of drivers and challenges - Market trends - Vendor landscape - Major Vendor Analysis 2015 - Key vendor analysis Companies Mentioned - Caliber Imaging & Diagnostic - FotoFinder Systems - Heine Optotechnik - Longport - MedX Health Corp. - Mela Sciences - Michelson Diagnostics - SciBase AB - Verisante Technology - Welch Allyn For more information visit http://www.researchandmarkets.com/research/fk9wjj/global
Verisante Enters Amended Licensing Agreement With the BC Cancer Agency
Marketwired - Thu Jul 09, 8:31AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in skin cancer detection technology, announced today that it has entered into an agreement that amends the licensing agreement (the "Agreement" originally entered into with the BC Cancer Agency ("BCCA" in July 2010. VRS.VN: 0.035 (unch)
North American Dermatology Treatment Devices Market 2015-2019 - Types (Liposuction, Microdermabrasion, Lasers) & Application (Cancer Diagnosis, Psoriasis, Hair Removal) Analysis
M2 - Tue May 26, 5:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/g3tbwq/north_american) has announced the addition of the "North American Dermatology Treatment Devices Market by Types (Liposuction, Microdermabrasion, Lasers) & by Application (Cancer Diagnosis, Psoriasis, Hair Removal) - Forecast to 2019" report to their offering. The North American dermatology treatment devices market is estimated to grow at a CAGR of 10.1% from 2014 to 2019 The U.S holds the largest share of the dermatology treatment devices market; however, the Canadian market is expected to grow at the highest CAGR of 11.5% during the forecast period. Factors such as rising skin disorders, growing demand for diagnosis from the geriatric population, increasing demand for dermatologists, and technology advantages are driving market growth. However, factors such as lack of awareness, competitive pricing of devices, and lack of dermatology care are hindering the growth of this market. In this report, the North American dermatology treatment devices market has been broadly classified on the basis of types. This includes LED light therapy devices, lasers, electrosurgical equipment, liposuction devices, microdermabrasion, and cryotherapy. The lasers segment held the largest share in the treatment devices market, growing at a CAGR of 12.3% during the forecast period. Geographically, the U.S commanded the largest share of 86.0% of the North American dermatology treatment devices market in 2014, followed by Canada. The dermatology treatment devices market in the U.S. is primarily driven by increasing demand from the geriatric population and rise in insurance coverage among citizens due to increasing employment. Canada is the fastest-growing market in the North American region, growing at a CAGR of 11.5% during the forecast period. The North American dermatology treatment devices market is a competitive market with a number of market players. As of 2014, the North American dermatology treatment devices market is estimated to be dominated by Photomedex, Inc., Verisante technology, Inc., MELA Sciences, Inc., Michelson diagnostics Ltd, Leica Microsystems, Fotofinder systems GMBH, FEI Company, Solta medical, Syneron medical Ltd., Lumenis Ltd., Cutera, Inc., Cynosure, Inc., AMD global telemedicine Inc, Ambicare Health Ltd, and ALMA Lasers, Ltd. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 North American Dermatology Treatment Devices Market, By Product 6 North American Dermatology Treatment Devices Market, By End User 7 North American Dermatology Treatment Devices Market, By Country 8 Dermatology Treatment Devices Market: Competitive Landscape 9 Dermatology Treatment Devices Market, By Company - ALMA Lasers, Ltd. - AMD Global Telemedicine Inc. - Ambicare Health Ltd - Cutera, Inc. - Cynosure, Inc. - FEI Company - Fotofinder Systems GMBH - LEICA Microsystems - Lumenis Ltd. - MELA Sciences, Inc. - Michelson Diagnostics Ltd. - Photomedex, Inc. - SOLTA Medical - Syneron Medical Ltd. - Verisante Technology, Inc. For more information visit http://www.researchandmarkets.com/research/g3...h_american
ELOS: 7.37 (-0.03), CYNO: 54.96 (+1.13), MELA: 1.12 (+0.01), LMNS: 13.76 (+0.04), FEIC: 106.42 (+0.12)
Asian Diagnostic Device Market 2015-2019: Analysis of Diagnostic Device (Dermatoscope, Microscope, Imaging Techniques) & Treatment Devices (Liposuction, Microdermabrasion, Lasers)
M2 - Thu May 07, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t9l5mt/asian_dermatology) has announced the addition of the "Asian Dermatology Diagnostic Devices Market by Diagnostic Device, by Treatment Device, by Application - Forecast to 2019" report to their offering. The Asian dermatology diagnostic devices market is estimated to grow at a CAGR of 6.5% from 2014 to 2019 Although mature markets such as China and Japan hold larger shares in the Asian Ddermatology diagnostic devices market, the Indian region is expected to grow at the highest CAGR of 7.3%. The growth of the Asian dermatology diagnostic devices market is driven by factors such as rising skin disorders, demand for diagnosis by baby boomers, demand for dermatologists, and technology advantages. However, factors such as a lack of awareness and dermatology care are hindering the growth of this market. The market, based on type of product, includes dermatoscopes, imaging techniques, and microscopes. Imaging techniques held the highest share in the market, growing at a CAGR of 7.0% during the forecast period. This is due to their use as in vivo tools; they also help in the detection of later stages of skin disorders. Geographically, China is estimated to have the largest share of 31.0% of the Asian Dermatology diagnostic devices market in 2014, followed by Japan. The dermatology diagnostic devices market in the China region is primarily driven by the increasing prevalence of skin disorders such as melanoma and psoriasis. The fastest-growing Indian market is driven by increasing insurance coverage and the awareness of various skin disorders in this region. The Asian dermatology diagnostic devices market is a competitive market, with a number of players. As of 2014, the Asian Dermatology diagnostic devices market is estimated to be dominated by Heine Optotechnik (Germany), Optomed Oy (Finland), FotoFinder Systems (Germany), Michelson Diagnostics (U.K.), GE Healthcare (U.K.), Philips Healthcare (Netherlands), Welch Allyn (U.S.), Carl Zeiss Meditec, Inc. (U.S.), Hitachi (Japan), Leica Microsystems (Germany), Olympus (Japan), Toshiba Medical Systems (Japan), and Siemens Healthcare (Germany). Companies Mentioned - AMD Global Telemedicine, Inc. - Bruker Corporation - Carl Zeiss - FEI Company - Fotofinder Systems Gmbh - GE Healthcare - Heine Optotechnik - Leica Microsystems - MELA Sciences, Inc. - Michelson Diagnostics Ltd. - Nikon Corporation - Philips Healthcare - Photomedex, Inc. - Siemens Healthcare - Toshiba Medical Systems - Verisante Technology, Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/t9...ermatology
MELA: 1.12 (+0.01), FEIC: 106.42 (+0.12)
Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019
M2 - Fri May 01, 5:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b8f54g/asian_dermatology) has announced the addition of the "Asian Dermatology Devices Market by Type, by End User - Forecast to 2019" report to their offering. The Asian Dermatology Devices market is estimated to grow at a CAGR of 11.3% from 2014 to 2019. China holds a larger share in the Dermatology devices market around 28.8% in 2014 followed by Japan. The Asian Dermatology Devices market holds a high potential for growth in future due to a number of forces favoring this market. These include increasing number of people suffering from skin disorders, demand for devices at a lower cost and increasing awareness aesthetic procedures. However, price sensitive market is having an adverse effect on the dermatology devices market. In this report, the Asian Dermatology devices market is broadly classified on the basis of product types, end users. The products segment is classified into Dermatology treatment devices and Dermatology diagnostic devices. Based on end users, the Dermatology devices market is categorized into Hospitals and Clinics. Geographically the market is divided into eight countries, namely Japan, China, India, Korea, Singapore, Malaysia, Indonesia and Rest of Asia (RoE). China is estimated to command the largest share of 28.7% of the Asian Dermatology Devices market in 2014, followed by Japan. Japan is estimated to grow at a CAGR of 7.9% during the forecast period from 2014 to 2019. Certain factors that influence the demand for the Asian dermatology devices market include the increasing number of people who suffer from skin disorders and the demand for devices at a lower cost. Thus, world-class manufacturers are coming up with devices at a lower price and concentrate on the Asian region to expand their business and geographical reach. Countries in the Asian region, namely India and China have a tropical climate, making the inhabitants of this region extremely prone to sun exposure, particularly skin tanning. Thus, there is an increase in the demand for dermatological treatments that have an impact on the growth of the dermatology diagnostic devices market in Asia. The number of skin cancer cases in Singapore has been increasing. There were 2,819 cases of skin cancer in Singapore from 2008 to 2012, among which 83.0% were Chinese, according to the National Skin Centre, followed by Malays recording 4.5% of the cases. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Asian Dermatology Devices Market, By Type 6 Asian Dermatology Devices Market, By End-User 7 Asian Dermatology Devices Market, By Geography 8 Asian Dermatology Devices Market: Competitive Landscape 9 Asian Dermatology Devices Market: Company Profiles - ALMA Lasers, Ltd. - Ambicare Health Ltd. - amd Global Telemedicine Inc - Applisonix Ltd - Biolitec0020AG - Carl Zeiss - Cynosure, Inc. - Ellipse A/S - fei Company - Fotofinder Systems GMBH - Genesis Biosystems. - Heine Optotechnik - Leica Microsystems - Lumenis Ltd. - Mela Sciences, Inc. - Michelson Diagnostics Ltd - Nikon Corporation - Photomedex, Inc. - Solta Medical, Llc. (Division of Valeant Pharmaceuticals North America, Llc.) - Syneron Medical Ltd - Verisante Technology, Inc. For more information visit http://www.researchandmarkets.com/research/b8...ermatology
ELOS: 7.37 (-0.03), CYNO: 54.96 (+1.13), LMNS: 13.76 (+0.04)
North American Dermatology Devices (Dermatology Treatment Devices, Dermatology Diagnostic Devices) Market 2015 - Forecast to 2019
M2 - Fri Apr 24, 5:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bk922d/north_american) has announced the addition of the "North American Dermatology Devices Market by Type (Dermatology Treatment Devices, Dermatology Diagnostic Devices) - Forecast to 2019" report to their offering. The North American dermatology diagnostic devices market is estimated to grow at a CAGR of 7.9% from 2014 to 2019 Although mature markets (the U.S. and Canada) command larger shares in the dermatology diagnostic devices market, Mexico is expected to grow at the highest CAGR of 9.8% during the forecast period. The growth of the dermatology diagnostic devices market is driven by factors such as rising incidences of skin disorders, increasing demand for diagnosis by baby boomers, need for more dermatologists, and technological advancements. However, factors such as lack of awareness, competitive pricing, and lack of dermatology care are hindering the growth of this market. In this report, the North American dermatology diagnostic devices market has been broadly classified on the basis of types. This segment includes dermatoscopes, imaging techniques, and microscopes. The imaging techniques segment commands the largest share of the dermatology diagnostic devices market, growing at a CAGR of 8.0% during the forecast period (2014 to 2019). This large share is mainly due to the fact that imaging techniques are generally in vivo tools and helps in the detection of later stages of skin disorders. The U.S commanded the largest share of 89.3% of the North American dermatology diagnostic devices market in 2014, followed by Canada. The dermatology diagnostic devices market in the U.S. is primarily driven by the increasing demand from baby boomers and increasing insurance coverage for citizens due to increasing employment. Mexico is the fastest-growing segment in the North American region, at a CAGR of 9.8% during the forecast period. This is due to the increasing insurance coverage and awareness of various skin disorders in this region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 North America Dermatology Devices Market, By Type 6 North America Dermatology Devices Market, By Geography 7 North America Dermatology Devices Market: Competitive Landscape 8 Dermatology Devices Market, By Company - Alma Lasers, Ltd. - Ambicare Health Ltd - Amd Global Telemedicine Inc. - Applisonix Ltd. - Biolitec Ag - Carl Zeiss Meditec - Cutera, Inc. - Cynosure, Inc. - Ellipse A/S - Fei Company - Fotofinder Systems Gmbh - Genesis Biosystems - Leica Microsystems - Lumenis Ltd. - Mela Sciences, Inc. - Michelson Diagnostics Ltd. - Nikon Corporation - Photomedex, Inc. - Solta Medical, - Syneron Medical Ltd. - Verisante Technology, Inc. For more information visit http://www.researchandmarkets.com/research/bk...h_american
ELOS: 7.37 (-0.03), CYNO: 54.96 (+1.13), LMNS: 13.76 (+0.04)
Global Dermatology Diagnostic Devices Market 2015-2019 - Type (Imaging Techniques, Dermatoscopes, Microscopes) & End-User (Hospitals, Clinics) Analysis
M2 - Wed Apr 22, 9:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5qq5d4/dermatology) has announced the addition of the "Dermatology Diagnostic Devices Market by Product [Imaging Techniques (OCT, Ultrasound, MRI, CT), Dermatoscopes (Traditional Dermatoscopes, Digital Dermatoscopes), Microscopes], by End-User (Hospitals, Clinics) - Global Forecast to 2019" report to their offering. The global dermatology diagnostic devices market is estimated to grow at a CAGR of 8.2% from 2014 to 2019 North America and Europe hold larger shares in the global dermatology diagnostic devices market. The growth of the global dermatology diagnostic devices market is mainly attributed to a wide range of factors, such as increasing incidence of skin disorders, growing demand of dermatologists, and technological advancements made in the field of medical science. However, lack of awareness and poor dermatology care are certain factors restraining the growth of this market. In this report, the global dermatology diagnostic devices market has been broadly classified on the basis of types. The type segment includes dermatoscope, imaging technique, and microscope. The imaging technique has the highest market share in the diagnostic device market, registering a CAGR of 8.5% during the forecast period. This growth is mainly triggered by the increasing significance of dermatology techniques and advantages it offers with respect to early detection of skin disorders. Geographically, North America is estimated to have the largest share of 37.1% in the global dermatology diagnostic devices market in 2014, followed by Europe. The dermatology diagnostic devices market in North America is primarily driven by the increasing prevalence of skin disorders, such as melanoma and psoriasis, and highly organized health care infrastructure and guidelines. The European region is the fastest growing region progressing at a CAGR of 9.6% from 2014 to 2019, owing to the increase in insurance coverage, incessant rise in geriatric population, and growing awareness about various skin disorders. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Dermatology Diagnostic Devices Market, By Product 6 Global Dermatology Diagnostic Devices Market, By Geography 7 Global Dermatology Diagnostic Devices Market, By End User 8 Global Dermatology Diagnostic Devices Market: Competitive Landscape 9 Global Dermatology Diagnostic Devices Market, By Company - AMD Global Telemedicine Inc - Bruker Corporation - Carl Zeiss - FEI Company - Fotofinder Systems Gmbh - GE Healthcare - Heine Optotechnik - Leica Microsystems - Mela Sciences, Inc. - Michelson Diagnostics Ltd - Nikon Corporation - Philips Healthcare - Photomedex, Inc. - Seimens Healthcare - Toshiba Medical Systems - Verisante Technology, Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/5q...ermatology
FEIC: 106.42 (+0.12)
Verisante Obtains Mexican Approval
Marketwired - Thu Mar 12, 9:02AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in skin cancer detection technology, announced today that it has received regulatory approval from the Federal Commission for Protection against Sanitary Risks (COFEPRIS), a division within the Mexican Ministry of Health, to market and sell Aura(TM), a device for the detection of skin cancer, in Mexico. VRS.VN: 0.035 (unch)
Verisante Technology, Inc. Announces Equipment Loan to Further Collaboration With Key Chinese Laboratory
Marketwired - Wed Feb 18, 9:01AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today it has expanded its collaboration with Fujian Normal University in China (the "University" . VRS.VN: 0.035 (unch)
Verisante Technology, Inc. Announces Brain Tumour Study in the UK
Marketwired - Tue Jan 13, 8:30AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today it has entered into a collaboration with the BC Cancer Agency and Imperial College Healthcare NHS Trust to develop a new application for the Company's exclusively licensed platform technology. VRS.VN: 0.035 (unch)
Verisante Technology, Inc. Announced Non-Brokered Private Placement and Year End Operational Update
Marketwired - Wed Dec 31, 8:31AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, today announced it has closed a non-brokered private placement of 3,888,889 common shares at a price of $0.09 per share for gross proceeds of $350,000. VRS.VN: 0.035 (unch)
